To Determine Whether Didrex 25 mg (Benzphetmine Hydrochloride) Tablets (NDA 12-427) by Pharmacia & Upjohn Company, Has Been Voluntarily Withdrawn or Withheld from Sale for Safety or Efficacy Reasons | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2008-P-0215

To Determine Whether Didrex 25 mg (Benzphetmine Hydrochloride) Tablets (NDA 12-427) by Pharmacia & Upjohn Company, Has Been Voluntarily Withdrawn or Withheld from Sale for Safety or Efficacy Reasons

Documents

Comments

Description

Status: CLOSED Closed per letter of 3/25/2010. (Correction, 3/26/2010)

Key Dates

Comment Period OpensJul 3, 2008

Documents

Type	Title	Posted	Comments	Status
Other	FDA Responses to Lachman Consultant Services Inc., March 25-26, 2010 - Letter/Correction Letter	Mar 29, 2010	--

Keywords

NDA 12-427

Tablets

benzphetamine hydrochloride

Didrex

CDER

Data from Regulations.gov